Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,978 | 3,727 | 1,712 | 5,504 | 4,390 |
| Marketable Securities | 5,009 | 7,086 | 11,054 | 11,198 | 14,749 |
| Receivables | N/A | 1,752 | 1,823 | 971 | 929 |
| TOTAL | $9,157 | $12,565 | $14,589 | $17,673 | $20,068 |
| Non-Current Assets | |||||
| PPE Net | 42 | 43 | 46 | 49 | 47 |
| Other Non-Current Assets | 84 | 98 | 111 | 125 | 138 |
| TOTAL | $126 | $141 | $157 | $174 | $185 |
| Total Assets | $9,283 | $12,706 | $14,746 | $17,847 | $20,253 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,671 | 1,930 | 1,288 | 2,031 | 1,859 |
| TOTAL | $2,502 | $2,796 | $2,153 | $2,904 | $2,730 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 783 | 818 | 818 | 818 | 818 |
| Other Non-Current Liabilities | 14 | 26 | 40 | 54 | 71 |
| TOTAL | $2,309 | $2,482 | $2,701 | $2,919 | $3,141 |
| Total Liabilities | $4,811 | $5,278 | $4,854 | $5,823 | $5,871 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 60,654 | 60,654 | 60,654 | 60,654 |
| Retained earnings | -150,847 | -147,828 | -145,299 | -143,108 | -140,674 |
| Other shareholders' equity | 1,127 | 1,127 | 1,127 | 1,127 | 1,127 |
| TOTAL | $4,472 | $7,428 | $9,892 | $12,024 | $14,382 |
| Total Liabilities And Equity | $9,283 | $12,706 | $14,746 | $17,847 | $20,253 |